A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors
Clinical trial NCT05499715 · UNKNOWN
Trial details
- NCT number
- NCT05499715
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-05-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.